Jaffe E A, Mosher D F
J Exp Med. 1978 Jun 1;147(6):1779-91. doi: 10.1084/jem.147.6.1779.
Plasma fibronectin is probably the major nonimmune particulate opsonin in blood and is cross-linked to fibrin during the final stage of blood coagulation. Fibronectin also occurs in an insoluble form in basement membranes especially those underlying endothelial cells and in loose connective tissue. Fibronectin was demonstrated in cultured human endothelial cells and in the surrounding extracellular matrix by immunofluorescence microscopy by using antibody to human plasma fibronectin. Cultured human endothelial cells released fibronectin into the culture medium which was immunologically identical to the fibronectin in human plasma. Cultured human endothelial cells were labeled with [3H] leucine. The radioactive fibronectin present in the endothelial postculture medium and in urea extracts of cellular monolayers was isolated with either anti-fibronectin coupled to Protein A-Sepharose or double antibody immunoprecipitation and characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. When reduced, the [3H] fibronectin synthesized by cultured endothelial cells had the same mol wt (approximately 200,000) as plasma fibronectin. Unreduced, the [3H] fibronectin synthesized by endothelial cells migrated as a dimer, as did plasma fibronectin. Fibronectin accounted for approximately 15% of the protein synthesized and released by endothelial cells into the culture medium. Thus, cultured endothelial cells synthesize fibronectin, secrete it into the culture medium, and incorporate it into extracellular matrix. The results suggest that the endothelial cell is potentially a major site of synthesis of circulating plasma fibronectin. In addition, fibronectin derived from endothelial cells may be an important structural component of the subendothelium.
血浆纤连蛋白可能是血液中主要的非免疫性颗粒调理素,并且在血液凝固的最后阶段与纤维蛋白交联。纤连蛋白也以不溶性形式存在于基底膜中,尤其是在内皮细胞下方的基底膜以及疏松结缔组织中。通过使用抗人血浆纤连蛋白抗体,采用免疫荧光显微镜技术在培养的人内皮细胞及其周围的细胞外基质中证实了纤连蛋白的存在。培养的人内皮细胞将纤连蛋白释放到培养基中,该纤连蛋白在免疫学上与人血浆中的纤连蛋白相同。用[3H]亮氨酸标记培养的人内皮细胞。通过与蛋白A-琼脂糖偶联的抗纤连蛋白或双抗体免疫沉淀法,从内皮细胞培养后培养基和细胞单层的尿素提取物中分离出放射性纤连蛋白,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳对其进行表征。还原后,培养的内皮细胞合成的[3H]纤连蛋白与血浆纤连蛋白具有相同的分子量(约200,000)。未还原时,内皮细胞合成的[3H]纤连蛋白与血浆纤连蛋白一样以二聚体形式迁移。纤连蛋白约占内皮细胞合成并释放到培养基中的蛋白质的15%。因此,培养的内皮细胞合成纤连蛋白,将其分泌到培养基中,并将其整合到细胞外基质中。结果表明,内皮细胞可能是循环血浆纤连蛋白的主要合成部位。此外,源自内皮细胞的纤连蛋白可能是内皮下的重要结构成分。